학술논문

Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.
Document Type
Article
Source
Frontiers in Psychiatry; 2024, p1-15, 15p
Subject
OBSESSIVE-compulsive disorder
PSILOCYBIN
TREATMENT delay (Medicine)
INSTITUTIONAL review boards
RANDOMIZED controlled trials
Language
ISSN
16640640
Abstract
Copyright of Frontiers in Psychiatry is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)